Tag Archives: Johnson and Johnson

Predicting Dissolution Quality With Fluid Bed Granulation

Last month, Steve Mehrman of Johnson & Johnson gave a presentation on using Fluid Bed Granulation as a predictor of dissolution performanceContinue reading

Chilworth’s Safe Scale-up of Chemical Processes

safe-scale-up-chemical-processes-webinar

Safe Scale-up of Chemical Processes

On July 1, Dr. Stephen Rowe of Chilworth Technology will present Safe Scale-up of Chemical Processes: Holistic Strategies Supported by Modern Tools.

This online process safety seminar will focus on the overall safety strategy and outlines:

Predictor of Dissolution Performance in Fluid Bed Granulation

In July, I announced that I would be chairing next week’s In Process Particle Forum  being held in Iselin, NJ.  Today, I want to highlight one of the papers that will be presented at In Process Particle ForumSteve Mehrman of Johnson & Johnson will present on using FBRM C35 during fluid bed granulation development and scale-up.

Continue reading

How Johnson and Johnson Replaced The Round Bottom Flask

Janssen Pharmaceutica Belgium is part of Johnson & Johnson, the world’s largest health care company. Thanks to Johnson and Johnson’s extensive engagement in innovative science, and investment in highly educated people and advanced research equipment, Janssen Pharmaceutica enjoys an international reputation for pharmaceutical innovation and quality. Continue reading

In Process Particle Forum: Liquid and Solid Dosage Formulations

I am excited to be chairing the upcoming In Process Particle Forum focused on Liquid and Solid Dosage Formulations on September 15 in Woodbridge, NJ. This will be the third year in a row that METTLER TOLEDO has brought together expert users of FBRM and PVM to present their cutting edge research to a group of their peers. This year, we have the best agenda yet with four industry papers from:

  • Bristol-Myers Squibb
  • Merck
  • Johnson and Johnson
  • GlaxoSmithKline

Continue reading

Reducing Time to Manufacturing Using Real-time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool – On-Demand Webinar

The on-demand version of the Reducing Time to Manufacturing Using Real-time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool webinar that I presented on January 20 is now available.

View the Reducing Time to Manufacturing On-Demand Webinar.

FTIR-Analytics-Process-Analytical-Technology-Will-Kowalchyk

During this on-demand webinar, I review case studies from the pharmaceutical industry to show how real-time mid-infrared (mid-IR) analytics provide critical information that results in shorter process development timelines, including:

  • Intermediate detection during an indazole alkylation and scale-up – Pfizer
  • Hazardous gas detection during tetrazole synthesis – Merck
  • Monitoring a Grignard reaction at the multikilogram scale – Bristol-Myers Squibb
  • Scale-up involving a sensitive enolate – Johnson and Johnson (J&J)

If you have any questions or would like to discuss this further, then please contact me.